Amid the escalating global burden of metabolic diseases, mouse models have emerged as pivotal tools in biomedical research, not only facilitating our profound understanding of the intricate pathological mechanisms underlying these complex disorders but also providing an invaluable platform for drug discovery and screening. 

GemPharmatech has strategically established a comprehensive collection of mouse strains related to metabolic diseases, encompassing models for obesity, diabetes, hyperlipidemia, atherosclerosis, osteoporosis, hyperuricemia, MASLD, and humanized models targeting various metabolic-related pathways. These models encompass a broad spectrum of applications, playing a crucial role in metabolic research due to their unique features. 

The themes of this webinar include:

- Introduction to Related Models of Diseases Such as Obesity, Diabetes, Liver Disease, Hypertension and Hyperuricemia

- Key Features and Guidelines for Model Selection

- Application of Human Gene Knock-In Models for Pharmacological Evaluation of Novel Therapies and Case Studies

Date:

Thursday, September 12, 2024

8:00 AM PDT | 10:00 AM CDT | 11:00 AM EDT | 5:00 PM CEST